- Home
- VCIG vs SILO Comparison
VCIG vs SILO Comparison
Compare VCIG & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCIG
- SILO
- Stock Information
- Founded
- VCIG 2013
- SILO 2010
- Country
- VCIG Malaysia
- SILO United States
- Employees
- VCIG N/A
- SILO N/A
- Industry
- VCIG Diversified Commercial Services
- SILO Apparel
- Sector
- VCIG Consumer Discretionary
- SILO Consumer Discretionary
- Exchange
- VCIG Nasdaq
- SILO Nasdaq
- Market Cap
- VCIG 7.5M
- SILO 8.0M
- IPO Year
- VCIG 2023
- SILO N/A
- Fundamental
- Price
- VCIG $1.20
- SILO $0.40
- Analyst Decision
- VCIG
- SILO
- Analyst Count
- VCIG 0
- SILO 0
- Target Price
- VCIG N/A
- SILO N/A
- AVG Volume (30 Days)
- VCIG 9.3M
- SILO 377.0K
- Earning Date
- VCIG 10-06-2025
- SILO 11-13-2025
- Dividend Yield
- VCIG N/A
- SILO N/A
- EPS Growth
- VCIG N/A
- SILO N/A
- EPS
- VCIG 0.98
- SILO N/A
- Revenue
- VCIG $32,903,041.00
- SILO $72,102.00
- Revenue This Year
- VCIG N/A
- SILO $1.86
- Revenue Next Year
- VCIG N/A
- SILO N/A
- P/E Ratio
- VCIG $1.20
- SILO N/A
- Revenue Growth
- VCIG 24.77
- SILO N/A
- 52 Week Low
- VCIG $0.91
- SILO $0.39
- 52 Week High
- VCIG $4,644.01
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- VCIG 37.80
- SILO 26.46
- Support Level
- VCIG $1.00
- SILO $0.39
- Resistance Level
- VCIG $2.18
- SILO $0.47
- Average True Range (ATR)
- VCIG 0.29
- SILO 0.04
- MACD
- VCIG 0.09
- SILO -0.01
- Stochastic Oscillator
- VCIG 23.28
- SILO 0.18
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.